Insel Gruppe AG, University Hospital Bern: Communicable Diseases trials

The registry lists 10 Communicable Diseases studies with Insel Gruppe AG, University Hospital Bern as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 4 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Closed Incision Negative Pressure Wound Therapy for the Prevention of Surgical Site Infections in Abdominal SurgeryNot yet recruitingNCT06068517Not applicable
• Bern Birth Cohort / Trajectory of Microbiota Maturation in Healthy Bern Infants - a Network ApproachRecruitingNCT04447742
• High-fat Diet (HFD) and Small Intestinal MicrobiomeCompletedNCT07019142Not applicable
• Networks of Bacterium-Metabolite Interactions in the Small IntestineTerminatedNCT04978077Not applicable
• Changing the Surgical Team for Wound Closure and Surgical Site InfectionCompletedNCT04503642
• Understanding the Drivers of Surgical Site Infection: Investigating and Modeling the Swissnoso Surveillance DataCompletedNCT03883009
• Optimized Perioperative Antibiotic Prophylaxis in Radical CystectomyCompletedNCT03305627Not applicable
• Impact of Structured Communication in the OR on Surgical Site Infections: Prospective Observational Clinical TrialCompletedNCT02428179
• Symptomatic Therapy of Uncomplicated Lower Urinary Tract Infections in the Ambulatory Setting.TerminatedNCT01039545Phase 4
• Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected PatientsCompletedNCT00973466